This is default featured slide 1 title

Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.

Market volatility derails Novartis' plan to sell stake in its India arm

Novartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strategic reviews and potential interest, fluctuations in stock prices and declining sales present hurdles in reaching a deal, with existing licensing agreements adding complexity. from Healthcare/Biotech-Industry-Economic...

360 ONE, Claypond Capital get CCI nod to acquire stakes in API Holdings

Fair trade regulator CCI has approved 360 ONE and Claypond Capital Partners' joint proposal to acquire stakes in API Holdings. This transaction involves purchasing compulsorily convertible preference shares from MEMG Family Office LLP, indicating oversight to prevent unfair business practices and ensure fair competition. from Healthcare/Biotech-Industry-Economic...

View: Will Trump's tariffs lift the veil on India's drug safety problem?

India’s pharmaceutical industry is facing potential tariffs imposed by President Trump, which could significantly impact exports, particularly to the US. High export dependence and questionable quality standards underscore the need for reform and improved regulation to maintain the industry’s reputation and market position. from Healthcare/Biotech-Industry-Economic...

Ankura Hospitals secures Rs 165 cr funding from ADB

Ankura Hospitals has secured Rs 165 crore in funding from the Asian Development Bank. This strategic investment will enhance its pediatric, maternity, and gynecology services, enabling the Hyderabad-based chain to expand its facilities and strengthen its presence in key cities across India. from Healthcare/Biotech-Industry-Economic Times https://ift.tt/hmIAXlY via...

KKR in talks to acquire US dental labs chain Leixir

Global investment firm KKR is in talks to acquire Leixir Dental Laboratory Group from Comvest Investment Partners at a valuation of $200-$250 million. Leixir, founded in 2013, offers various dental solutions and operates facilities in the US and India. Deloitte is advising on the sale process. from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Aeon5HM via...

From AI to Telemedicine: Digital skills every healthcare professional should learn

Digital skills are crucial for healthcare professionals, with growing fields like telemedicine, AI-driven diagnostics, and data analytics. Continuous learning in electronic health records, cybersecurity, and emerging technologies like 3D printing and robotics is vital for those seeking to stay relevant and succeed in the evolving healthcare landscape. from...

Eli Lilly working on a heart drug that may benefit Indians: CEO David Ricks

Eli Lilly is developing a groundbreaking drug, lepodisiran, to combat high LPA cholesterol levels prevalent in South Asians, potentially reducing it by 85%-90%. With heart disease cases surging in India, this phase 3 trial drug promises significant cardiovascular benefits, requiring only once-a-year administration. It's crucial, given the rising heart...